46 research outputs found
Complications related to deep venous thrombosis prophylaxis in trauma: a systematic review of the literature
Deep venous thrombosis prophylaxis is essential to the appropriate management of multisystem trauma patients. Without thromboprophylaxis, the rate of venous thrombosis and subsequent pulmonary embolism is substantial. Three prophylactic modalities are common: pharmacologic anticoagulation, mechanical compression devices, and inferior vena cava filtration. A systematic review was completed using PRISMA guidelines to evaluate the potential complications of DVT prophylactic options. Level one evidence currently supports the use of low molecular weight heparins for thromboprophylaxis in the trauma patient. Unfortunately, multiple techniques are not infrequently required for complex multisystem trauma patients. Each modality has potential complications. The risks of heparin include bleeding and heparin induced thrombocytopenia. Mechanical compression devices can result in local soft tissue injury, bleeding and patient non-compliance. Inferior vena cava filters migrate, cause inferior vena cava occlusion, and penetrate the vessel wall. While the use of these techniques can be life saving, they must be appropriately utilized
A rare case report of acyclovir-induced immune thrombocytopenia with tongue hematomas as the first sign, and a literature review
Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis
Severe thrombocytopenia following intraarterial papaverine administration for the treatment of vasospasm
Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa
Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka/Bakb alloantigen system
Polymorphism of human platelet membrane glycoprotein IIb associated with the Baka/Bakb alloantigen system
Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/thrombosis
none5mixedBACSI S; DE PALMA R; VISENTIN GP; GORSKI J; ASTER RHBacsi, S; DE PALMA, R; Visentin, Gp; Gorski, J; Aster, R